𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of des-γ-carboxy prothrombin as a marker protein of hepatocellular carcinoma

✍ Scribed by Yoshihiro Deyashiki; Yoshimi Nishioka; Katsumi Takahashi; Yoshitane Kosaka; Koji Suzuki

Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
455 KB
Volume
64
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma abnormal prothrombin (Des-γ-carbo
Plasma abnormal prothrombin (Des-γ-carboxy prothrombin) as a marker of hepatocellular carcinoma
✍ Shigetoshi Fujiyama; Takafumi Morishita; Osamu Hashiguchi; Tatsuo Sato 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 732 KB

Des-y-carboxy prothrombin [DCP], a protein induced by vitamin K absence or antagonist-I1 and also abbreviated PIVKA-11, was evaluated as a serologic marker for hepatocellular carcinoma (HCC). Its plasma levels were measured by enzyme immunoassay (E-1023) using an anti-DCP monoclonal antibody in 514

The des-γ-carboxy prothrombin index is a
The des-γ-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma
✍ Sakae Nagaoka; Hiroshi Yatsuhashi; Hisayuki Hamada; Koji Yano; Takehiro Matsumot 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

## Abstract ## BACKGROUND Des‐γ‐carboxy prothrombin (DCP) has been reported to be an important prognostic factor in patients with hepatocellular carcinoma (HCC). Recently, a monoclonal antibody, 19B7, which recognizes the Gla domain of DCP, has been identified. The 19B7 antibody recognizes an epit

Usefulness of simultaneous determination
Usefulness of simultaneous determination of α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma
✍ Akimasa Nakao; Kenji Taniguchi; Soichiro Inoue; Akio Harada; Toshiaki Nonami; Ke 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB

Serum y-fetoprotein (AFP) and plasma des-y-carboxy prothrombin (DCP), a protein induced by vitamin K absence or antagonist I1 (PIVKA-11) levels, were measured in 197 patients with primary hepatocellular carcinoma (HCC). DCP levels were determined by conventional enzyme immunoassay kit (E-1023) and a

Evaluation of CA 125 as a serum marker o
Evaluation of CA 125 as a serum marker of hepatocellular carcinoma
✍ John Elias; Michael C. Kew 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 331 KB

## Abstract Serum CA 125 concentrations were raised in 90.4% of 115 southern African black patients with hepatocellular carcinoma. Seventy‐four percent of 62 patients with amebic hepatic abscess, 60% of 40 patients with chronic hepatic parenchymal disease (chronic hepatitis or cirrhosis), and 60.9%

The usefulness of determining des-γ-carb
The usefulness of determining des-γ-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma
✍ Yuhsaku Mita; Yutaka Aoyagi; Masahiko Yanagi; Takeshi Suda; Yasufumi Suzuki; Hit 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

## Background: Measurements of serum concentrations of des-gamma-carboxy prothrombin (dcp) are widely used for diagnosing hepatocellular carcinoma (hcc). however, the dcp is not always sensitive enough to detect small hccs. in the current study, the authors investigated the usefulness of dcp in the